Medplus Health Services · NSE: MEDPLUS · BSE: 543427
Q2 FY23 results · Jul–Sep 2022
Medplus Health Services reported revenue from operations of ₹1,120.62 crore and net profit of ₹6.48 crore for Q2 FY23 (Jul–Sep 2022), on a consolidated basis.
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,120.62 | — | — | 993.65 | +12.8% |
| Other income | 10.89 | — | — | 10.13 | +7.5% |
| Total income | 1,131.52 | — | — | 1,003.78 | +12.7% |
| Profit before tax | 8.82 | — | — | 4.87 | +81.3% |
| Net profit for the period | 6.48 | — | — | 3.68 | +76.1% |
| Attributable to shareholders of the company | 6.57 | — | — | 3.20 | +105.2% |
| EPS, basic (₹) | 0.55 | — | — | 0.27 | +103.7% |
| Net margin (%) | 0.6 | — | 0.4 |
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 42.45 | — | — | 27.29 | +55.6% |
| Other income | 4.26 | — | — | 5.37 | −20.5% |
| Total income | 46.72 | — | — | 32.65 | +43.1% |
| Profit before tax | (0.82) | — | — | 0.04 | Turned loss |
| Net profit for the period | (0.82) | — | — | 0.04 | Turned loss |
| EPS, basic (₹) | (0.07) | — | — | 0.00 | — |
| Net margin (%) | -1.9 | — | 0.1 |
Consolidated
- Filed with BSE
- 24 Nov 2022, 10:14 IST
- Board meeting
- 11 Nov 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 24 Nov 2022, 10:14 IST
- Board meeting
- 11 Nov 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE